JP2001520663A5 - - Google Patents

Download PDF

Info

Publication number
JP2001520663A5
JP2001520663A5 JP1998544901A JP54490198A JP2001520663A5 JP 2001520663 A5 JP2001520663 A5 JP 2001520663A5 JP 1998544901 A JP1998544901 A JP 1998544901A JP 54490198 A JP54490198 A JP 54490198A JP 2001520663 A5 JP2001520663 A5 JP 2001520663A5
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP1998544901A
Other languages
English (en)
Japanese (ja)
Other versions
JP3608800B2 (ja
JP2001520663A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP1998/001773 external-priority patent/WO1998042318A1/en
Publication of JP2001520663A publication Critical patent/JP2001520663A/ja
Application granted granted Critical
Publication of JP3608800B2 publication Critical patent/JP3608800B2/ja
Publication of JP2001520663A5 publication Critical patent/JP2001520663A5/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

JP54490198A 1997-03-26 1998-03-18 抗真菌剤およびポリマーでコートされたコアを有するペレット剤 Expired - Lifetime JP3608800B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP97200914 1997-03-26
EP97200914.6 1997-03-26
PCT/EP1998/001773 WO1998042318A1 (en) 1997-03-26 1998-03-18 Pellets having a core coated with an antifungal and a polymer

Publications (3)

Publication Number Publication Date
JP2001520663A JP2001520663A (ja) 2001-10-30
JP3608800B2 JP3608800B2 (ja) 2005-01-12
JP2001520663A5 true JP2001520663A5 (cg-RX-API-DMAC7.html) 2005-02-10

Family

ID=8228147

Family Applications (1)

Application Number Title Priority Date Filing Date
JP54490198A Expired - Lifetime JP3608800B2 (ja) 1997-03-26 1998-03-18 抗真菌剤およびポリマーでコートされたコアを有するペレット剤

Country Status (30)

Country Link
EP (1) EP0969821B1 (cg-RX-API-DMAC7.html)
JP (1) JP3608800B2 (cg-RX-API-DMAC7.html)
KR (1) KR100520936B1 (cg-RX-API-DMAC7.html)
CN (1) CN1206984C (cg-RX-API-DMAC7.html)
AP (1) AP1227A (cg-RX-API-DMAC7.html)
AT (1) ATE241969T1 (cg-RX-API-DMAC7.html)
AU (1) AU734248B2 (cg-RX-API-DMAC7.html)
BG (1) BG64434B1 (cg-RX-API-DMAC7.html)
BR (1) BR9806174A (cg-RX-API-DMAC7.html)
CA (1) CA2269501C (cg-RX-API-DMAC7.html)
CY (1) CY2384B1 (cg-RX-API-DMAC7.html)
CZ (1) CZ295502B6 (cg-RX-API-DMAC7.html)
DE (1) DE69815316T2 (cg-RX-API-DMAC7.html)
DK (1) DK0969821T3 (cg-RX-API-DMAC7.html)
EE (1) EE03904B1 (cg-RX-API-DMAC7.html)
ES (1) ES2201485T3 (cg-RX-API-DMAC7.html)
HU (1) HU224217B1 (cg-RX-API-DMAC7.html)
ID (1) ID21477A (cg-RX-API-DMAC7.html)
IL (1) IL129575A (cg-RX-API-DMAC7.html)
NO (1) NO325102B1 (cg-RX-API-DMAC7.html)
NZ (1) NZ335364A (cg-RX-API-DMAC7.html)
OA (1) OA11162A (cg-RX-API-DMAC7.html)
PL (1) PL190566B1 (cg-RX-API-DMAC7.html)
PT (1) PT969821E (cg-RX-API-DMAC7.html)
RU (1) RU2218153C2 (cg-RX-API-DMAC7.html)
SI (1) SI0969821T1 (cg-RX-API-DMAC7.html)
SK (1) SK284813B6 (cg-RX-API-DMAC7.html)
TR (1) TR199900990T2 (cg-RX-API-DMAC7.html)
UA (1) UA60318C2 (cg-RX-API-DMAC7.html)
WO (1) WO1998042318A1 (cg-RX-API-DMAC7.html)

Families Citing this family (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK1104291T3 (da) 1998-07-17 2006-01-16 Janssen Pharmaceutica Nv Pelleter med en kerne, som er coatet med et antisvampemiddel og en polymer
ES2157731B1 (es) * 1998-07-21 2002-05-01 Liconsa Liberacion Controlada Preparacion farmaceutica oral de un compuesto de actividad antifungica y procedimiento para su preparacion.
DK1163234T3 (da) 1999-03-24 2006-02-27 Scherer Technologies Inc R P Farmaceutiske formuleringer med forbedret vandoplöselighed
KR100432949B1 (ko) * 2000-06-13 2004-05-31 코오롱제약주식회사 생체이용율이 향상된 이트라코나졸의 분립체 조성물과이를 이용한 이트라코나졸 제제 및 그 제조방법
US6663897B2 (en) * 2001-02-06 2003-12-16 Dsm Ip Assets B.V. Oral itraconazole formulations and methods of making the same
EP1370543B1 (en) 2001-02-14 2006-10-25 Tibotec Pharmaceuticals Ltd. Broadspectrum 2-(substituted-amino)-benzothiazole sulfonamide hiv protease inhibitors
EP1397367A2 (en) 2001-04-09 2004-03-17 Tibotec Pharmaceuticals Ltd. Broadspectrum 2-(substituted-amino)-benzoxazole sulfonamide hiv protease inhibitors
US7622490B2 (en) 2001-05-11 2009-11-24 Tibotec Pharmaceuticals, Ltd. Broadspecturm 2-amino-benzoxazole sulfonamide HIV protease inhibitors
WO2002100407A1 (en) * 2001-06-12 2002-12-19 Smartrix Technologies Inc. Itraconazole granulations: pharmaceutical formulations for oral administration and method of preparing same
US8071133B2 (en) 2001-08-20 2011-12-06 Stiefel Laboratories, Inc. Oral dosage forms of water insoluble drugs and methods of making the same
US7763641B2 (en) 2001-12-21 2010-07-27 Tibotec Pharmaceuticals Ltd. Broadspectrum heterocyclic substituted phenyl containing sulfonamide HIV protease inhibitors
MY142238A (en) 2002-03-12 2010-11-15 Tibotec Pharm Ltd Broadspectrum substituted benzimidazole sulfonamide hiv protease inhibitors
CA2485903C (en) 2002-05-17 2011-08-16 Tibotec Pharmaceuticals Ltd. Broadspectrum substituted benzisoxazole sulfonamide hiv protease inhibitors
NZ538714A (en) 2002-08-14 2007-03-30 Tibotec Pharm Ltd Broadspectrum substituted oxindole sulfonamide HIV protease inhibitors
KR100557680B1 (ko) * 2002-11-23 2006-03-07 한국유나이티드제약 주식회사 이트라코나졸의 용해도 개선을 위한 펠렛제제 및 그제조방법
DK1438960T4 (da) * 2003-01-14 2013-03-25 Cimex Pharma Ag Sammensætning af itraconazol dispergeret i en hydrofil polymer med forhøjet biotilgængelighed
DK1438961T4 (da) * 2003-01-14 2014-11-17 Acino Pharma Ag Bioækvivalent sammensætning af itraconazol dispergeret i en hydrofil polymer
EP1651192A1 (en) 2003-08-06 2006-05-03 Nirmal Mulye Pharmaceutical composition containing water soluble drug
CA2531766C (en) 2003-09-11 2012-11-27 Tibotec Pharmaceuticals Ltd. Entry inhibitors of the hiv virus
EP1568369A1 (en) 2004-02-23 2005-08-31 Boehringer Ingelheim Vetmedica Gmbh Use of meloxicam for the treatment of respiratory diseases in pigs
AR048650A1 (es) 2004-05-04 2006-05-10 Tibotec Pharm Ltd Derivados de (1,10b-dihidro-2-(aminocarbonil-fenil)-5h-pirazolo[1,5 c][1,3]benzoxazin-5-il)fenil metanona como inhibidores de la replicacion viral del vih
AU2005244121B2 (en) 2004-05-07 2012-01-19 Sequoia Pharmaceuticals, Inc. Resistance-repellent retroviral protease inhibitors
MXPA06013315A (es) 2004-05-17 2007-02-02 Tibotec Pharm Ltd 1,5-dihidro-pirido[3,2-b]indol-2-onas 4-sustituidas.
TW200607502A (en) 2004-05-17 2006-03-01 Tibotec Pharm Ltd 6, 7, 8, 9-substituted 1-phenyl-1, 5-dihydro-pyrido[3, 2-b]indol-2-ones
KR20070015608A (ko) 2004-05-17 2007-02-05 티보텍 파마슈티칼즈 리미티드 1-헤테로사이클일-1,5-디히드로-피리도[3,2-b]인돌-2-온
RU2008143342A (ru) 2006-04-03 2010-05-10 Тиботек Фармасьютикалз Лтд. (Ie) 3, 4-дигидроимидазо(4, 5-b)пиридин-5-оны, ингибирующие вич(hiv)
KR20090065524A (ko) * 2006-09-04 2009-06-22 파나세아 바이오테크 리미티드 프로그래머블 부력전달기술
KR100809903B1 (ko) * 2006-09-05 2008-03-06 주식회사유한양행 안정화된 클로피도그렐-함유 입자, 그의 제조방법, 및 이를포함하는 약학 조성물
CN101283984B (zh) * 2007-04-12 2010-05-26 永胜药品工业股份有限公司 高生物使用率的经杀真菌剂和聚合物涂覆的核心微粒状物
JP2008280254A (ja) * 2007-05-08 2008-11-20 Everest Pharm Industrial Co Ltd 生体に使用される比率が高い、殺菌剤と重合物を塗粧してる核心微粒状物
US8313527B2 (en) 2007-11-05 2012-11-20 Allergan, Inc. Soft prosthesis shell texturing method
JP5745855B2 (ja) 2007-11-28 2015-07-08 セコイア、ファーマシューティカルズ、インコーポレイテッドSequoia Pharmaceuticals,Inc. シトクロムp450 2d6を阻害するための組成物および方法
CA2716348C (en) 2008-02-21 2017-04-04 Sequoia Pharmaceuticals, Inc. Diamide inhibitors of cytochrome p450
US9050184B2 (en) 2008-08-13 2015-06-09 Allergan, Inc. Dual plane breast implant
US8877822B2 (en) 2010-09-28 2014-11-04 Allergan, Inc. Porogen compositions, methods of making and uses
US9138309B2 (en) 2010-02-05 2015-09-22 Allergan, Inc. Porous materials, methods of making and uses
US9205577B2 (en) 2010-02-05 2015-12-08 Allergan, Inc. Porogen compositions, methods of making and uses
GB2479213B (en) 2010-04-01 2013-07-10 Theravida Inc Pharmaceutical formulations for the treatment of overactive bladder
CN102971018B (zh) * 2010-05-11 2016-02-03 阿勒根公司 致孔剂组合物、制备方法及用途
US11202853B2 (en) 2010-05-11 2021-12-21 Allergan, Inc. Porogen compositions, methods of making and uses
US8679279B2 (en) 2010-11-16 2014-03-25 Allergan, Inc. Methods for creating foam-like texture
CN102100678B (zh) * 2011-02-18 2012-10-17 天津力生制药股份有限公司 伊曲康唑硫酸盐微丸及其制备方法
AU2013359158B2 (en) 2012-12-13 2018-08-02 Allergan, Inc. Device and method for making a variable surface breast implant
US10092392B2 (en) 2014-05-16 2018-10-09 Allergan, Inc. Textured breast implant and methods of making same
KR102600541B1 (ko) * 2016-01-20 2023-11-08 테라비다, 인코포레이티드 다한증을 치료하기 위한 방법 및 조성물
MX2020010673A (es) * 2018-04-16 2020-10-28 Bristol Myers Squibb Co Formulaciones de apixaban.
CN114767636B (zh) * 2022-04-11 2023-11-07 苏州中化药品工业有限公司 伊曲康唑微丸、制备方法及伊曲康唑微丸胶囊

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3346123A1 (de) * 1983-12-21 1985-06-27 Janssen Pharmaceutica, N.V., Beerse Pharmazeutische praeparate von in wasser schwerloeslichen oder instabilen arzneistoffen und verfahren zu ihrer herstellung
GB8506792D0 (en) * 1985-03-15 1985-04-17 Janssen Pharmaceutica Nv Derivatives of y-cyclodextrin
USH672H (en) * 1986-12-31 1989-09-05 E. R. Squibb & Sons, Inc. Stable antifungal capsule formulation
EP0374531B1 (en) * 1988-12-22 1994-05-04 American Cyanamid Company Method for the treatment of periodontal disease by sustained delivery of a therapeutic agent to the periodontal pocket, composition of matter therefor and apparatus for the administration thereof
PH30929A (en) * 1992-09-03 1997-12-23 Janssen Pharmaceutica Nv Beads having a core coated with an antifungal and a polymer.
CA2258683C (en) * 1996-06-28 2007-07-31 Schering Corporation Oral composition comprising a triazole antifungal compound

Similar Documents

Publication Publication Date Title
JP2000510751A5 (cg-RX-API-DMAC7.html)
JP2000509942A5 (cg-RX-API-DMAC7.html)
JP2000509912A5 (cg-RX-API-DMAC7.html)
JP2000509635A5 (cg-RX-API-DMAC7.html)
JP2000507042A5 (cg-RX-API-DMAC7.html)
JP2000509637A5 (cg-RX-API-DMAC7.html)
JP2001520831A5 (cg-RX-API-DMAC7.html)
JP2002507351A5 (cg-RX-API-DMAC7.html)
JP2000509587A5 (cg-RX-API-DMAC7.html)
JP2000508866A5 (cg-RX-API-DMAC7.html)
JP2000510793A5 (cg-RX-API-DMAC7.html)
JP2000508022A5 (cg-RX-API-DMAC7.html)
JP2000508841A5 (cg-RX-API-DMAC7.html)
JP2001522504A5 (cg-RX-API-DMAC7.html)
JP2001517982A5 (cg-RX-API-DMAC7.html)
JP2002508745A5 (cg-RX-API-DMAC7.html)
JP2000508680A5 (cg-RX-API-DMAC7.html)
JP2000509804A5 (cg-RX-API-DMAC7.html)
JP2001511650A5 (cg-RX-API-DMAC7.html)
JP2000509755A5 (cg-RX-API-DMAC7.html)
JP2000510969A5 (cg-RX-API-DMAC7.html)
JP2000508102A5 (cg-RX-API-DMAC7.html)
JP2000509818A5 (cg-RX-API-DMAC7.html)
JP2000509520A5 (cg-RX-API-DMAC7.html)
JP2000507434A5 (cg-RX-API-DMAC7.html)